Topical formulation development has been Dow?s focus for 32 years. Each year Dow develops new prescription formulations for 20-25 clients. With this amount of experience, we know how to anticipate and avoid the problems. During 2005-08, the FDA approved 25 topical product NDAs and 10 (40%) were formulated at Dow.
* Indicates required fields
Privacy Statement: The information you provide here will be sent to the company from whom you are requesting information and will not be used by the owners of this website for any other purpose. Read our Privacy Policy
*
First Name
*
Last Name
*
Email Address
Company
Address
Address 2
City
State
Zip Code
Work Phone
Product Questions / Comments